Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
125 Cards in this Set
- Front
- Back
Fibrocystic breast changes
|
Breast tissue changing in response to hormonal, nutritional, physical, and/or environmental stimult
|
|
When do fibrocystic breast changes usually occur
|
30-50 yrs of age
|
|
Pharm- FBC
|
OC, progesterone, synthetic androgen, tamoxifen, vit-E, special diets
|
|
Most common cancer in woman
|
Breast Cancer
|
|
Most significant risk factors
|
Female, over 50, + fam history,
|
|
Breast Cancer gene
|
BRCA1 BRCA2
|
|
Most common type of breast cancer
|
Invasive ductal carcinoma 75-85%
|
|
Metastasis of breast cancer
|
bloodstream of lymphatic system
|
|
sites of metastasis of breast cancer
|
bone, brain, lung, liver, skin, and lymph nodes
|
|
Screening age 20-39
|
clinical breast exam q 3 yrs
|
|
Screening age 40+
|
clinical breast exam q year
|
|
Screening age 40+
|
Mammogram q year for as long as the woman is in good health
|
|
Diagnostic test for breast cancer
|
Mammogram, ultrasound, MRI, PET, Biopsy
|
|
Types of biopsies
|
Aspiration
Incisional Excisional Core Sentinel node biopsy |
|
When is radiation used in breast cancer
|
if lymph node involved, chest wall involved, chest wall involved, or tumor larger than 5cm
|
|
Types if breast surgeries
|
Radical mastectomy
Modified radical mastectomy simple mastectomy segmental or lumpectomy reconstruction surgery |
|
Txn: for breast cancer
|
Tamoxifen- anti-estrogen
Chemotherapy Surgery |
|
Cyst
|
fluid filled sac.
|
|
Polyp
|
Vascular solid tumor attached by a stem.
|
|
Cyst/Polyps can occur:
|
in the vulva, cervix, endometrium,or ovary
|
|
Bartholin Cyst
|
most common in the vulva. Caused by infection or obstruction
|
|
Cervical Polyp
|
Most common benign cervical. Usually in ppl over age. Possibly develops from endocervical hyperplasia. At vaginal end of cervix
|
|
Endometrial cyst/polyps
|
Caused by endometrial overgrowth and often filled w/ old blood (chocolate cyst) polyps are untrauterine growths.
|
|
Ovarian cyst (PCOS)
|
numerous follicular cyst
|
|
Diagnostic test of benign cyst and polyps
|
WBC & LH level, pregnancy test, laparoscopy, C&S, u/s, x-ray
|
|
Pharm:
|
ATB, OC
|
|
Surgery
|
Cervical polyp removal
Endometrial polyp removal by transcervical approach Bartholins Cyst- I&D Ovarian cys- cystectomy, oopherectomy |
|
PMS
|
Recurrent symptoms days before menstruation
Common age - 30-40 25-30% report symptoms |
|
Affective symptoms
|
Psychological
irritability depression |
|
Somatic symptoms
|
cramping
fatigue |
|
Pharmacology
|
Multi-V
vit-E Calcium Magnesium NSAID'S OC's Antidepressants Anxiolytics Diuretics |
|
DUB
|
Vaginal Bleeding- usually painless but abnormal in amount, duration, or timing.
|
|
Most frequently reported healthcare problem
|
DUB
|
|
Leading cause of hysterectomy
|
DUB
|
|
Possible causes of DUB
|
stress, wt. change, OC and IUD use, hormonal imbalance, PCOS, steroid therapy, hypothyroidism, etc.
|
|
Diagnostic and lab testing for DUB
|
CBC, PT, thyroid function test, endocrine work up, progesterone levels, pap, hCG, pelvis u/s, hysteroscopy, endometrial bx, menstrua history, basal body temp for several months.
|
|
Pharmacology DUB
|
estrogen, progestin, OC's, NSAID's, levonorgestrel-20 intrauterine device, iron salts
|
|
Surgery DUB
|
D&C
Endometrial ablation Hysterectomy |
|
Dysmenorrhea
|
Painful menstruation
>50% of woman, increase prostaglandin production by endometrium causing muscle fibers to contract. |
|
Diagnostic and lab testing for dysmenorrhea
|
pap, cultures, CBC, UA, FSH, LH, progesterone, estradiol, thyroid, vaginal/pelvic u/s, CT, MRI, sed rate, guaiac stool, laparoscopy, D&C
|
|
Pharm:
Lifestyle changes: |
NSAID'S, COX- inhibitors, OC's
diet, exercise, wt. loss, relaxation, smoking cessation |
|
Amenorrhea
|
Absence of menses during reproductive year.
|
|
Primary amenorrhea
|
abscence by 14 w/ absence of development of secondary sex chararistics or absence by 16 w/ normal development.
|
|
Etiology of amenorrhea
|
Primary: extreme wt. gain/loss, congenital, stress, increase exercise, eating disorders, PCOS, cushings disease, hypothyroidism, chronic illness
Secondary: pregnancy, lactation, stress, certain tumors, depression, rapid wt. change, early menopause. |
|
Secondary amenorrhea
|
absence for 3 cycles or 6 months when woman was regular.
|
|
Diagnostic and lab testing for pt w/ amenorrhea includes
|
H&P, physical assesment, karyotype, u/s, hCG, throid function test, prolactin, FSH, LH, 17-ketosteroids, laparoscopy, CT of head to see pituitary.
|
|
Txn for secondary amenorrhea
|
progesterone, bromocriptine, GnRH, thyroid replace
|
|
Menopause (climacteric)
|
Permanant cessation of menses
between 35-58 average 50 |
|
Causes of menopause can be
|
Natural biologic, surgical, or chemical
|
|
Manifestations of menopause
|
affects brain, breasts, cardiovascular, skeletal, GU, GI, integumentary and body shape
|
|
Benefits of HRT
|
Lowers the risk of CAD by 50%
Reduce the risk of bone loss & osteoporosis |
|
Risk and side effects of HRT
|
Change in vaginal bleeding pattern, breast tenderness/engorgement, HA, depression, chest pain, GB disease, GI distress, endometrial/ovarian CA, and breast CA
|
|
Increase risk of chest pain and heart attack
|
increased by 29%
|
|
Pelvic Organ Prolase degrees
|
1st degree- prolapse into vaginal canal
2nd degree- cervix descends into vaginal introitus (procidentia) 3rd degree- Cervix below vaginal introitus |
|
Cause of Pelvic Organ Prolapse
|
erect posture, aging, decrease in estrogen, childbirth, surgery, pelvic radiation, and increased abdominal pressure.
|
|
Collaborative care
|
H&P
Txn: Kegals, ERT, lifestyle changes, and pessasaries |
|
Cystocele
|
Txn: anterior colporrhaphy, MMK
shortens the pelvic muscles, suport for the bladder |
|
Rectocele
|
Txn: posterior colporrhaphy
shortens the pelvic muscles, to aid in support of the rectum |
|
Prolapsed Uterus
|
repositioned and muscles shortened to provide support; hysterectomy
|
|
Uterine Fibroid Tumors (leiomyomas)
|
solid pedunculated benign tumors 50% in women older than 30. Most common indication for hystercomy in U.S.
|
|
Positions of leiomymomas
|
Intramural, sub-serous, or submucous.
|
|
Symptoms of leiomymomas
|
pelvic pain, low back pain, bloating, infertility, dysmenorrhea, dyspareunia, anemia, and feeling "heavy"
|
|
Txn:
|
GnRH agonist, uterine artery embolization, myomectomy,laser surgery, and hysterectomy.
|
|
Postmenopausal calcium intake
|
1200-1500mg daily
|
|
Vitamin D intake
|
400-600 iu daily
|
|
Vitamin E intake
|
100mg daily
|
|
Vaginal Fistulas
|
Abnormal opening/passage between two organs or spaces normally seperated or abnormal passafe outside of the body
|
|
Diagnosed:
|
by pelvic examination; dye into the bladder to help identify vesicovagina fistula.
|
|
Cancer is the __ leading cause of death for women in the united states.
|
2nd
|
|
Assessment of pt w/ cancer includes
|
health history (personal and family)
Physical exam Laboratory and diagnostic testing |
|
Most common gynecological cancer in the u.s
|
Endometrial/Uterine Cancer
|
|
Average age of pts w/ endometrial cancer
|
50-70
|
|
95% of endometrial cancers are ___
|
carcinomas
|
|
Risk factors for endometrial cancer
|
Early menarche, late menopause, h/o infertility, anovulation, nulliparity, extened use of tamoxifen(anti-estrogen hormone), obesity, diabetes, and hight fat diet.
|
|
Endometrial cancer can metastisize to:
|
Lungs, inguinal/supraclavicular nodes, brain, vagina, liver, and bone
|
|
Laboratory and diagnostic testing
|
Vaginal u/s, CBC, endometrial biopsy
|
|
Pharm
|
Progesterone therapy for recurrent disease.
|
|
surgery:
|
TAH&BSO, radical hysterectomy w/ node disesction
|
|
Cervical cancer 5 yr survival rate
|
73%
|
|
Median age when diagnosed
|
47 (ages 35-50)
|
|
More than 90% is caused by
|
HPV
|
|
Risk factors for cervical cancer
|
early 1st intercourse, low socioeconomic status, promiscuous male partners, unprotected sex, family history, sec w/ uncircumcised male, smoking HIV, OC, etc.
|
|
Gardasil Vaccine prevents wich strains of HPV
|
6,11,16,18 9-26 yrs old for vaccine
|
|
Testing for cervical cancer
|
pap, colposcopy & biopsy, MRI, CT
|
|
PHARM:
|
Chemotherapy used for tumors not respomsive to other therapy, tumors than cannot be removed, or as adjunct therapy.
|
|
Surgery:
|
laser surgery with colposcopy, cryosurgery, conization, hysterectomy, pelvic, or anterior exenteration.
|
|
Vaginal Cancer
|
Rare malignant tissue growth arising in vagina <3% of genital cancers
2000 new cases 800 deaths peak age 60-65 |
|
About 85% are
|
squamous cell carcinomas
|
|
Txn of Vaginal cancers
|
radiation, laser surgery
|
|
Ovarian cancer is the 2nd most common gynecological cancer
|
True
|
|
Common age for ovarian cancer
|
55-75
|
|
Ovarian cancer risk factors
|
+ family history, advancing age, late 1st pregnancy, nulliparity, history of breast CA, long term HRT use, BRCA1 and BRCA2
|
|
90% of Ovarian tumors are
|
epithelial tumors
|
|
Laboratory and diagnostic testing of ovarian CA
|
laparoscopy, pap, CA125, BE, proctoscopy, IVP, u/s, CT, X-ray,
|
|
pharmacology for ovarian cancer
|
Chemotherapy may be used to achieve remission. Taxol may be effective.
|
|
Surgery for ovarian cancer
|
Removal of one ovary, total hysterectomy w/ BSO and removal of omentum, second look in 6 mths.
|
|
Endometriosis
(diagnostic and laboratory testing) |
pelvic u/s, CBCw/ diff, laparoscopy w/ biopsy
|
|
Cancer of the Vulva
|
4th most common gynecologucal cancer. usually after age 60
|
|
5 yr survival if vulva
|
85-90% if early
|
|
Surgery for vulvar cancer
|
laser surgery, cryosurgery, electrocautery, vulvectomy (skinning, simple, or radical.
|
|
PID
|
Inflammation of the uterine tubes, ovaries, cervix, uterus, & peritoneum.
|
|
Number of hospital stays/ yr
|
200,000
|
|
Manifestations of PID
|
high fever, vaginal discharge, severe lower abd pain, nausea, malaise, dysuria, infertility, & increased risk of ectopic pregnancy, abscess, dyspareunia, dysmenorrhea.
|
|
Laboratory and Diagnostic test for PID
|
clinical exam, CBC, endocervical or cervical culture, laparoscopy, or laparotomy.
|
|
Pharmacology for PID
|
combination ATB therapy,
Tetracycline, PCN, quinolones, cephalosporins. |
|
Surgery of PID
|
drain abscess, remove adhesions, hysterectomy
|
|
Toxic shock syndrome
|
Rare acute caused by staphylococcus aures r/t tampon use
|
|
Testing for Toxic shock syndrome
|
WBC, Bun, Creat, SGOT, SGPT, platelet count, vaginal and blood culture
|
|
Pharmacology for toxic shock syndrome
|
IV beta-lactamase-resistent ATB
|
|
Primary cause of dysmenorrhea
|
Endometriosis
|
|
Destroys uterine lining
|
Endometrial ablation
|
|
Biggest risk factor for cervical cancer
|
+family history
|
|
#1 txn for vulva CA
|
vulvectomy
|
|
Post menopausal bleeding is usually caused by
|
HRT
|
|
Pts not on HRT need to take in atleast _____ of vit-D
|
400-600 iu
|
|
Menstrual cycle lasting longer than 35 days
|
Oligomenorrhea
|
|
Endometriosis is the most common gynecological diagnosis responsible for hospitalization of females in which age group?
|
15-44 yr olds
|
|
Which procedure is done to visualize the pelvic cavity to assist in making a diagnosis of endometriosis
|
laparoscopy
|
|
Of the wimen referred to endometriosis centers what percentage had dysmenorrhea?
|
75%
|
|
One of the most common sites for endometrial lesions are the
|
ovaries
|
|
Anti-estrogen drug used to treat estrogen receptor + breast CA
|
Tamoxifen (Nolvadex)
|
|
Prevents estrogen from being made in the body
|
aromatase inhibitors
|
|
Aromatase Inhibitors
|
anastrozole (Arimidex)
letrozole (Femara) exemestane (Aromasin) |
|
Drug that works by bnding to estrogen receptors and changing their shape
|
fulvestrant (Faslodex)
|
|
Drugs that interferen with estogen's ability to fuel metastatic breast cancer growth include fluoxymestrone
|
fluoxymestrone (Halotestin) and megestrol (Megace)
|